[Analysis of non-communicable disease prevention and control policy implementation in China from 2014 to 2021].

X K Wang, H Li, J H Guo, R Y Zhang, F Y Cui, W L Dong
{"title":"[Analysis of non-communicable disease prevention and control policy implementation in China from 2014 to 2021].","authors":"X K Wang, H Li, J H Guo, R Y Zhang, F Y Cui, W L Dong","doi":"10.3760/cma.j.cn112150-20241024-00845","DOIUrl":null,"url":null,"abstract":"<p><p>This study utilized data from the non-communicable diseases (NCDs) Progress Monitor Reports (2015, 2017, 2020, 2022) released by World Health Organization (WHO) to analyze the implementation of NCDs prevention and control policies in China from 2014 to 2021 through descriptive statistical method, aiming to provide evidence for strengthening national NCDs strategies. The analysis focuses on WHO-recommended 'best buys' policies for NCDs prevention and control, covering 10 categories (18 interventions): national NCDs targets, mortality data, risk factor surveys, national integrated NCDs policies/strategies/action plans, tobacco demand-reduction measures, harmful use of alcohol reduction measures, unhealthy diet reduction policies, physical activity campaigns, national clinical guidelines for cancer/CVD/diabetes/CRD management, and drug therapy/counselling for cardiovascular diseases. In accordance with the WHO's NCDs progress monitor scoring methodology, policies are assigned 1.0 point for full implementation, 0.5 points for partial implementation, and 0 points for non-implementation or missing data, with a maximum total score of 18.0 points. The analytical metrics encompass the policy implementation score, implementation rate, and period-on-period implementation growth rate. The results showed that China's total policy implementation scores for NCDs prevention and control in 2014, 2016, 2019, and 2021 were consistently higher than the global average (8.5, 10.5, 9.5, 9.5 <i>vs</i> 6.7, 8.3, 8.6, 8.6). From 2014 to 2021, the total score increased by 1.0 point, and the implementation rate improved by 8.9%. From 2014 to 2016, China's total policy implementation score rose from 8.5 to 10.5, primarily driven by improvements in tobacco tax increases and unhealthy diet reduction measures (salt reduction, restrictions on high-fat foods, and regulation of breast-milk substitute sales). However, this progress was partially offset by a decline in scores for physical activity campaigns. From 2016 to 2019, the total score decreased to 9.5, largely due to lower scores in harmful use of alcohol reduction measures (alcohol taxation and advertising bans). From 2019 to 2021, the total score remained stable, with increases in marketing to children restrictions balanced by declines in scores for drug therapy/counselling for cardiovascular diseases. In 2021, China's total policy implementation score (9.5) exceeded the global average (8.6) but fell below the G20 average (11.2). Significant gaps remained compared to top-performing G20 countries such as Turkey (16.5), particularly in tobacco control and restrictions on harmful alcohol use. In conclusion, from 2014 to 2021, China's total policy implementation score for NCDs prevention and control consistently exceeded the global average, demonstrating an upward trend, and various NCDs prevention and control policies have been continuously improved.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 3","pages":"328-335"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华预防医学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112150-20241024-00845","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

This study utilized data from the non-communicable diseases (NCDs) Progress Monitor Reports (2015, 2017, 2020, 2022) released by World Health Organization (WHO) to analyze the implementation of NCDs prevention and control policies in China from 2014 to 2021 through descriptive statistical method, aiming to provide evidence for strengthening national NCDs strategies. The analysis focuses on WHO-recommended 'best buys' policies for NCDs prevention and control, covering 10 categories (18 interventions): national NCDs targets, mortality data, risk factor surveys, national integrated NCDs policies/strategies/action plans, tobacco demand-reduction measures, harmful use of alcohol reduction measures, unhealthy diet reduction policies, physical activity campaigns, national clinical guidelines for cancer/CVD/diabetes/CRD management, and drug therapy/counselling for cardiovascular diseases. In accordance with the WHO's NCDs progress monitor scoring methodology, policies are assigned 1.0 point for full implementation, 0.5 points for partial implementation, and 0 points for non-implementation or missing data, with a maximum total score of 18.0 points. The analytical metrics encompass the policy implementation score, implementation rate, and period-on-period implementation growth rate. The results showed that China's total policy implementation scores for NCDs prevention and control in 2014, 2016, 2019, and 2021 were consistently higher than the global average (8.5, 10.5, 9.5, 9.5 vs 6.7, 8.3, 8.6, 8.6). From 2014 to 2021, the total score increased by 1.0 point, and the implementation rate improved by 8.9%. From 2014 to 2016, China's total policy implementation score rose from 8.5 to 10.5, primarily driven by improvements in tobacco tax increases and unhealthy diet reduction measures (salt reduction, restrictions on high-fat foods, and regulation of breast-milk substitute sales). However, this progress was partially offset by a decline in scores for physical activity campaigns. From 2016 to 2019, the total score decreased to 9.5, largely due to lower scores in harmful use of alcohol reduction measures (alcohol taxation and advertising bans). From 2019 to 2021, the total score remained stable, with increases in marketing to children restrictions balanced by declines in scores for drug therapy/counselling for cardiovascular diseases. In 2021, China's total policy implementation score (9.5) exceeded the global average (8.6) but fell below the G20 average (11.2). Significant gaps remained compared to top-performing G20 countries such as Turkey (16.5), particularly in tobacco control and restrictions on harmful alcohol use. In conclusion, from 2014 to 2021, China's total policy implementation score for NCDs prevention and control consistently exceeded the global average, demonstrating an upward trend, and various NCDs prevention and control policies have been continuously improved.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[2014 - 2021年中国非传染性疾病防控政策实施情况分析]。
本研究利用世界卫生组织(WHO)发布的《非传染性疾病进展监测报告(2015、2017、2020、2022)》数据,通过描述性统计方法分析2014 - 2021年中国非传染性疾病防控政策实施情况,旨在为加强国家非传染性疾病战略提供依据。该分析侧重于世卫组织建议的非传染性疾病预防和控制“最划算”政策,涵盖10类(18项干预措施):国家非传染性疾病目标、死亡率数据、风险因素调查、国家非传染性疾病综合政策/战略/行动计划、减少烟草需求措施、减少有害使用酒精措施、减少不健康饮食政策、体育活动运动、国家癌症/心血管疾病/糖尿病/慢性疾病管理临床指南,以及心血管疾病的药物治疗/咨询。根据世卫组织的非传染性疾病进展监测评分方法,全面实施政策为1.0分,部分实施政策为0.5分,未实施或数据缺失政策为0分,总分最高为18.0分。分析指标包括政策执行得分、执行率和周期间执行增长率。结果显示,2014年、2016年、2019年和2021年,中国非传染性疾病防控政策执行总分均高于全球平均水平(8.5、10.5、9.5、9.5 vs 6.7、8.3、8.6、8.6)。2014年至2021年,总分提高1.0分,执行率提高8.9%。从2014年到2016年,中国政策执行总分从8.5分上升到10.5分,主要得益于烟草税上调和减少不健康饮食措施(减盐、限制高脂肪食品和监管母乳代用品销售)的改善。然而,这一进步部分被体育活动得分的下降所抵消。从2016年到2019年,总分降至9.5分,主要原因是有害使用酒精减少措施(酒精税和广告禁令)得分较低。从2019年到2021年,总分保持稳定,针对儿童的营销限制的增加与心血管疾病药物治疗/咨询得分的下降相平衡。2021年,中国政策执行总分(9.5)高于全球平均水平(8.6),但低于G20平均水平(11.2)。与表现最好的20国集团国家,如土耳其(16.5)相比,差距仍然很大,特别是在烟草控制和限制有害酒精使用方面。综上所述,2014 - 2021年,中国非传染性疾病防控政策执行总分持续超过全球平均水平,且呈上升趋势,各项非传染性疾病防控政策不断完善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
中华预防医学杂志
中华预防医学杂志 Medicine-Medicine (all)
CiteScore
1.20
自引率
0.00%
发文量
12678
期刊介绍: Chinese Journal of Preventive Medicine (CJPM), the successor to Chinese Health Journal , was initiated on October 1, 1953. In 1960, it was amalgamated with the Chinese Medical Journal and the Journal of Medical History and Health Care , and thereafter, was renamed as People’s Care . On November 25, 1978, the publication was denominated as Chinese Journal of Preventive Medicine . The contents of CJPM deal with a wide range of disciplines and technologies including epidemiology, environmental health, nutrition and food hygiene, occupational health, hygiene for children and adolescents, radiological health, toxicology, biostatistics, social medicine, pathogenic and epidemiological research in malignant tumor, surveillance and immunization.
期刊最新文献
[Guidance for the use of prophylactic monoclonal antibodies against respiratory syncytial virus in primary care]. [Research progress on risk factors and risk prediction of cardiovascular diseases related to antiphospholipid syndrome]. [Progress towards the varicella vaccination in China]. [Analysis of clinical characteristics in 105 cases of vulvar lichen sclerosus in girls]. [Clinical characteristics and investigation for the first death case of group Y epidemic cerebrospinal meningitis in Henan Province, 2024].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1